C4 Therapeutics, Inc. (CCCC)
NASDAQ: CCCC · Real-Time Price · USD
3.960
-0.380 (-8.76%)
At close: Jun 3, 2026, 4:00 PM EDT
4.000
+0.040 (1.01%)
After-hours: Jun 3, 2026, 7:55 PM EDT
C4 Therapeutics Market Cap
C4 Therapeutics has a market cap or net worth of $436.32 million as of June 3, 2026. Its market cap has increased by 299.01% in one year.
Market Cap
436.32M
Enterprise Value
226.49M
1-Year Change
299.01%
Ranking
Category
Stock Price
$3.96
Market Cap Chart
Since the IPO on October 2, 2020, C4 Therapeutics's market cap has decreased from $772.72M to $436.32M, a decrease of -43.54%. That is a compound annual growth rate of -9.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 3, 2026 | 436.32M | 135.71% |
| Dec 31, 2025 | 185.11M | -27.16% |
| Dec 31, 2024 | 254.12M | -8.73% |
| Dec 29, 2023 | 278.44M | -3.60% |
| Dec 30, 2022 | 288.85M | -81.55% |
| Dec 31, 2021 | 1.57B | 9.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 2, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| 4D Molecular Therapeutics | 512.31M |
| Kyverna Therapeutics | 509.36M |
| Prothena Corporation | 504.16M |
| Autolus Therapeutics | 493.70M |
| Contineum Therapeutics | 492.00M |
| Ovid Therapeutics | 485.26M |
| Eupraxia Pharmaceuticals | 470.57M |
| Forte Biosciences | 469.41M |